REPORT ID 2410

EMEA (Europe, Middle East and Africa) Hemostasis Devices Market Report 2017

Publish Date
8-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Hemostasis Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Hemostasis Devices for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hemostasis Devices market competition by top manufacturers/players, with Hemostasis Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Olympus
    RevMedx
    Z-Medica
    Argon Medical Devices
    C.R. Bard
    TZ Medical
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Topical Hemostasis
    Infusible Hemostasis

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Trauma
    Surgery
    Hemophilia
    Myocardial Infarction
    Stroke
    Thrombosis

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Hemostasis Devices Market Report 2017
1 Hemostasis Devices Overview
    1.1 Product Overview and Scope of Hemostasis Devices
    1.2 Classification of Hemostasis Devices
        1.2.1 EMEA Hemostasis Devices Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Hemostasis Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Topical Hemostasis
        1.2.4 Infusible Hemostasis
    1.3 EMEA Hemostasis Devices Market by Application/End Users
        1.3.1 EMEA Hemostasis Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Trauma
        1.3.3 Surgery
        1.3.4 Hemophilia
        1.3.5 Myocardial Infarction
        1.3.6 Stroke
        1.3.7 Thrombosis
    1.4 EMEA Hemostasis Devices Market by Region
        1.4.1 EMEA Hemostasis Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Hemostasis Devices (2012-2022)
        1.5.1 EMEA Hemostasis Devices Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Hemostasis Devices Revenue and Growth Rate (2012-2022)

2 EMEA Hemostasis Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Hemostasis Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA Hemostasis Devices Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Hemostasis Devices Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Hemostasis Devices Sale Price by Players (2012-2017)
    2.2 EMEA Hemostasis Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA Hemostasis Devices Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Hemostasis Devices Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Hemostasis Devices Sale Price by Type (2012-2017)
    2.3 EMEA Hemostasis Devices (Volume) by Application
    2.4 EMEA Hemostasis Devices (Volume and Value) by Region
        2.4.1 EMEA Hemostasis Devices Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Hemostasis Devices Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Hemostasis Devices Sales Price by Region (2012-2017)

3 Europe Hemostasis Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Hemostasis Devices Sales and Value (2012-2017)
        3.1.1 Europe Hemostasis Devices Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Hemostasis Devices Revenue and Growth Rate (2012-2017)
    3.2 Europe Hemostasis Devices Sales and Market Share by Type
    3.3 Europe Hemostasis Devices Sales and Market Share by Application
    3.4 Europe Hemostasis Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Hemostasis Devices Sales Volume by Countries (2012-2017)
        3.4.2 Europe Hemostasis Devices Revenue by Countries (2012-2017)
        3.4.3 Germany Hemostasis Devices Sales and Growth Rate (2012-2017)
        3.4.4 France Hemostasis Devices Sales and Growth Rate (2012-2017)
        3.4.5 UK Hemostasis Devices Sales and Growth Rate (2012-2017)
        3.4.6 Russia Hemostasis Devices Sales and Growth Rate (2012-2017)
        3.4.7 Italy Hemostasis Devices Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Hemostasis Devices Sales and Growth Rate (2012-2017)

4 Middle East Hemostasis Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Hemostasis Devices Sales and Value (2012-2017)
        4.1.1 Middle East Hemostasis Devices Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Hemostasis Devices Revenue and Growth Rate (2012-2017)
    4.2 Middle East Hemostasis Devices Sales and Market Share by Type
    4.3 Middle East Hemostasis Devices Sales and Market Share by Application
    4.4 Middle East Hemostasis Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Hemostasis Devices Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Hemostasis Devices Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Hemostasis Devices Sales and Growth Rate (2012-2017)
        4.4.4 Israel Hemostasis Devices Sales and Growth Rate (2012-2017)
        4.4.5 UAE Hemostasis Devices Sales and Growth Rate (2012-2017)
        4.4.6 Iran Hemostasis Devices Sales and Growth Rate (2012-2017)

5 Africa Hemostasis Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Hemostasis Devices Sales and Value (2012-2017)
        5.1.1 Africa Hemostasis Devices Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Hemostasis Devices Revenue and Growth Rate (2012-2017)
    5.2 Africa Hemostasis Devices Sales and Market Share by Type
    5.3 Africa Hemostasis Devices Sales and Market Share by Application
    5.4 Africa Hemostasis Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Hemostasis Devices Sales Volume by Countries (2012-2017)
        5.4.2 Africa Hemostasis Devices Revenue by Countries (2012-2017)
        5.4.3 South Africa Hemostasis Devices Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Hemostasis Devices Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Hemostasis Devices Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Hemostasis Devices Sales and Growth Rate (2012-2017)

6 EMEA Hemostasis Devices Manufacturers/Players Profiles and Sales Data
    6.1 Olympus
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Hemostasis Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Olympus Hemostasis Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 RevMedx
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Hemostasis Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 RevMedx Hemostasis Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Z-Medica
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Hemostasis Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Z-Medica Hemostasis Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Argon Medical Devices
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Hemostasis Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Argon Medical Devices Hemostasis Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 C.R. Bard
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Hemostasis Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 C.R. Bard Hemostasis Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 TZ Medical
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Hemostasis Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 TZ Medical Hemostasis Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Hemostasis Devices Manufacturing Cost Analysis
    7.1 Hemostasis Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Hemostasis Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Hemostasis Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Hemostasis Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Hemostasis Devices Market Forecast (2017-2022)
    11.1 EMEA Hemostasis Devices Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Hemostasis Devices Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Hemostasis Devices Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Hemostasis Devices Price and Trend Forecast (2017-2022)
    11.2 EMEA Hemostasis Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Hemostasis Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Hemostasis Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Hemostasis Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Hemostasis Devices Sales Forecast by Type (2017-2022)
    11.7 EMEA Hemostasis Devices Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer